USA:

Europe:

Email:

Consultation

PD-L1 ELISA Kit

  • Product Information
  • Description
Catalog: C-EL-1881T
Product Type: Test kit
Size: 96 tests
Principle: Solid Phase Sandwich ELISA
Conjugation: HRP
Species: Human
Detection range: 10.94-700 pg/mL
Sensitivity: 5.56 pg/mL
Specificity: Recognizes both recombinant and natural Human PD-L1
Interference: Preparations of the factors listed below at 50 ng/mL in a mid-range recombinant human PD-L1 control were assayed for interference. No significant interference was observed.
Sample type: Serum,Cell supernatant,Plasma
Test type: Quantitative
Analysis mode: ELISA
Shipping: This ELISA Kit is shipped at ambient temperature.
Storage: 2-8℃
Full name: CD274 molecule
Application: Cancer Drug Targets

This PD-L1 ELISA Kit, Human is an enzyme-linked immunosorbent assay for the quantitative measurement of Human PD-L1 protein in Serum,Cell supernatant,Plasma . It contains recombinant Human PD-L1, and antibodies raised against the recombinant protein. This ELISA kit is complete and ready-to-use.Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.

Verification Code
top